4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Qol Holdings Co., Ltd. (3034) operates in the Pharmaceutical Retailers industry and is headquartered in Tokyo, Japan with about 6,247 employees. Its market capitalization is roughly JPY 91 billion. In the fiscal year ended 2026-03-31, 3034 reported JPY 290.8B in revenue and JPY 7.4B in net income.
Qol Holdings Co., Ltd., together with its subsidiaries, engages in the pharmacy, BPO, and pharmaceutical businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | JPY 290.8B | JPY 264.0B | JPY 180.1B | JPY 170.0B |
| Gross Profit | JPY 40.9B | JPY 39.1B | JPY 23.2B | JPY 23.5B |
| Operating Income (EBIT) | JPY 14.8B | JPY 13.5B | JPY 8.3B | JPY 9.5B |
| Net Income | JPY 7.4B | JPY 5.2B | JPY 4.9B | JPY 5.7B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 1.5B) | (JPY 1.2B) | (JPY 1.2B) | (JPY 1.1B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 158.1B | JPY 159.7B | JPY 117.8B | JPY 101.9B | — |
| Total Liabilities | JPY 98.3B | JPY 97.5B | JPY 64.9B | JPY 53.1B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3034 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms